Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University Hospital, Zürich | OTHER |
Not provided
Not provided
Not provided
Gestational diabetes mellitus (GDM), defined as hyperglycemia with blood glucose values above normal but below those diagnostic of DM, and iron deficiency (ID) with or without anemia (IDA) are common during pregnancy. Both disease patterns are associated with an increased risk of complications during pregnancy and at delivery and may have a variety of negative effects on different aspects of child development. Thus, GDM and ID/IDA during pregnancy should be prevented.
Whether iron supplementation with high oral doses acutely increases hepcidin during pregnancy, and whether this acute iron-induced increase in hepcidin decreases insulin sensitivity, is uncertain.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| High Iron Group | Active Comparator | 15 women taking 100 mg iron twice daily for 4 days (800 mg). |
|
| Low Iron Group | Active Comparator | 15 women taking 30 mg iron once daily for 14 days (420 mg). |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| 100mg iron fumarate | Dietary Supplement | 100mg iron fumarate b.i.d. for 4 consecutive days |
|
| Measure | Description | Time Frame |
|---|---|---|
| Serum hepcidin | before OGTT, 1 day before high/low iron supplementation | |
| Serum hepcidin | after OGTT, 1 day before high/low iron supplementation | |
| Serum hepcidin | before OGTT, after high/low iron supplementation at day 7 | |
| Serum hepcidin | after OGTT, after high/low iron supplementation at day 7 | |
| Serum iron | before OGTT, 1 day before high/low iron supplementation | |
| Serum iron | after OGTT, 1 day before high/low iron supplementation | |
| Serum iron | before OGTT, after high/low iron supplementation at day 7 | |
| Serum iron | after OGTT, after high/low iron supplementation at day 7 | |
| glucose | before OGTT, 1 day before high/low iron supplementation | |
| glucose | after OGTT, 1 day before high/low iron supplementation | |
| glucose | before OGTT, after high/low iron supplementation at day 7 |
| Measure | Description | Time Frame |
|---|---|---|
| Serum ferritin | before OGTT, 1 day before high/low iron supplementation | |
| Serum ferritin | after OGTT, 1 day before high/low iron supplementation | |
| Serum ferritin |
Not provided
Inclusion Criteria:
Willing to either:
Exclusion Criteria:
pregnancy
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Nicole U Stoffel, PhD | Contact | +41 44 632 83 93 | nicole.stoffel@hest.ethz.ch |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Human Nutrition Laboratory ETH Zurich | Recruiting | Zurich | 8092 | Switzerland |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D019189 | Iron Metabolism Disorders |
| D018149 | Glucose Intolerance |
| D016640 | Diabetes, Gestational |
| ID | Term |
|---|---|
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D006943 | Hyperglycemia |
| D044882 | Glucose Metabolism Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Burgerstein Schwangerschaft & Stillzeit | Dietary Supplement | contains 30 mg iron fumarate, given on 14 consecutive days |
|
| glucose | after OGTT, after high/low iron supplementation at day 7 |
| insulin | before OGTT, 1 day before high/low iron supplementation |
| insulin | after OGTT, 1 day before high/low iron supplementation |
| insulin | before OGTT, after high/low iron supplementation at day 7 |
| insulin | after OGTT, after high/low iron supplementation at day 7 |
| Serum hepcidin | At day 14, 7 days after high iron supplementation and 1 day after low iron supplementation |
| Serum iron | At day 14, 7 days after high iron supplementation and 1 day after low iron supplementation |
| glucose | At day 14, 7 days after high iron supplementation and 1 day after low iron supplementation |
| insulin | At day 14, 7 days after high iron supplementation and 1 day after low iron supplementation |
| before OGTT, after high/low iron supplementation at day 7 |
| Serum ferritin | after OGTT, after high/low iron supplementation at day 7 |
| soluble transferrin receptor | before OGTT, 1 day before high/low iron supplementation |
| soluble transferrin receptor | after OGTT, 1 day before high/low iron supplementation |
| soluble transferrin receptor | before OGTT, after high/low iron supplementation at day 7 |
| soluble transferrin receptor | after OGTT, after high/low iron supplementation at day 7 |
| c-reactive protein | before OGTT, 1 day before high/low iron supplementation |
| c-reactive protein | after OGTT, 1 day before high/low iron supplementation |
| c-reactive protein | before OGTT, after high/low iron supplementation at day 7 |
| c-reactive protein | after OGTT, after high/low iron supplementation at day 7 |
| alpha glycoprotein | before OGTT, 1 day before high/low iron supplementation |
| alpha glycoprotein | after OGTT, 1 day before high/low iron supplementation |
| alpha glycoprotein | before OGTT, after high/low iron supplementation at day 7 |
| alpha glycoprotein | after OGTT, after high/low iron supplementation at day 7 |
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D003920 | Diabetes Mellitus |
| D004700 | Endocrine System Diseases |